Yaya Issifou, Patassi Akouda Akessiwè, Landoh Dadja Essoya, Bignandi Essodjèlouna Manani, Kolani Kanfitine, Namoro Abdel-Daim Daou, Patchali P'Niwè Massoubayo, Djalogue Lihanimpo, Ekouevi Didier Koumavi, Saka Bayaki
Aix Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.
ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
BMJ Open. 2018 Apr 24;8(4):e019006. doi: 10.1136/bmjopen-2017-019006.
Contraceptive use among HIV-infected women in Togo is poorly documented. We aim at assessing the prevalence of modern contraceptive use and associated factors among HIV-infected women in Togo.
Cross-sectional study.
The study was conducted in five HIV care centres in the Centrale and Kara regions in Togo.
We included 461 HIV-positive women aged between 15 and 49 years and who were sexually active.
The outcome variable was HIV-infected women who were using modern contraceptive methods.
A total of 461 HIV-infected women were interviewed, with an average age of 34.3 (±7.1). Among them, 332 (73.1%) women reported using contraceptive methods, mostly condom alone (74.7%) or in combination with hormonal contraceptive (16.9%). In multivariate analysis, education level (primary: adjusted OR (aOR)=1.99, 95% CI (1.05 to 3.76); secondary level and higher: aOR=3.95, 95% CI (2.03 to 7.67)), WHO clinical stage (stage II: aOR=0.7, 95% CI (0.37 to 1.33)), follow-up in private care facilities (aOR=2.54, 95% CI (1.22 to 5.29)) and having a child (aOR=2.51, 95% CI (1.41 to 4.5)) were associated with higher contraceptive use, while marital status (living in union: aOR=0.45, 95% CI (0.28 to 0.74)) and WHO stages III and IV (aOR=0.47, 95% CI (0.24 to 0.94)) were associated with lower contraceptive use.
About three-quarters of sexually active HIV-infected women in Togo were using contraceptive methods, and private health facilities favoured this contraceptive use. It is important to strengthen the implementation of interventions to increase the incentives for HIV-infected women to use contraception in Togo.
多哥感染艾滋病毒女性的避孕情况记录甚少。我们旨在评估多哥感染艾滋病毒女性中现代避孕方法的使用 prevalence 及相关因素。
横断面研究。
该研究在多哥中部和卡拉地区的五个艾滋病毒护理中心进行。
我们纳入了461名年龄在15至49岁之间且有性活动的艾滋病毒阳性女性。
观察变量为使用现代避孕方法的感染艾滋病毒女性。
共采访了461名感染艾滋病毒的女性，平均年龄为34.3岁（±7.1）。其中，332名（73.1%）女性报告使用了避孕方法，主要是仅使用避孕套（74.7%）或与激素避孕法联合使用（16.9%）。在多变量分析中，教育水平（小学：调整后的比值比（aOR）=1.99，95%置信区间（CI）（1.05至3.76）；中学及以上：aOR=3.95，95%CI（2.03至7.67））、世界卫生组织临床分期（II期：aOR=0.7，95%CI（0.37至1.33））、在私立医疗机构接受随访（aOR=2.54，95%CI（1.22至5.29））以及育有子女（aOR=2.51，95%CI（1.41至4.5））与较高的避孕使用率相关，而婚姻状况（同居：aOR=0.45，95%CI（0.28至0.74））以及世界卫生组织III期和IV期（aOR=0.47，95%CI（0.24至0.94））与较低的避孕使用率相关。
多哥约四分之三有性活动的感染艾滋病毒女性使用了避孕方法，私立医疗机构更倾向于这种避孕方式的使用。加强干预措施的实施以增加多哥感染艾滋病毒女性使用避孕措施的激励措施非常重要。
